Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

J Torre-Cisneros, JM Aguado, JJ Caston… - Transplantation …, 2016 - Elsevier
Cytomegalovirus (CMV) infection remains a major complication of solid organ
transplantation. Because of management of CMV is variable among transplant centers, in …

[HTML][HTML] Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts

T Da Cunha, GY Wu - Journal of Clinical and Translational …, 2021 - ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV) infection is common and affects between 40–100% of the
worldwide population. However, the majority of cases are asymptomatic and when severe …

Human cytomegalovirus

RL Hodinka - Manual of clinical microbiology, 2015 - Wiley Online Library
Cytomegalovirus (CMV) belongs to a large family of herpesviruses that commonly infect
humans of all ages. Although infections with this virus are normally asymptomatic in healthy …

Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at …

C Martin-Gandul, P Pérez-Romero, M Sánchez… - Journal of clinical …, 2013 - Elsevier
BACKGROUND: Valganciclovir preemptive therapy guided by the viral load is the current
strategy recommended for preventing CMV disease in CMV-seropositive Solid Organ …

[HTML][HTML] Cytomegalovirus infection in the bone marrow transplant patient

V Bhat, A Joshi, R Sarode, P Chavan - World journal of …, 2015 - ncbi.nlm.nih.gov
Cytomegalovirus (CMV) infection is an important contributor to the morbidity and mortality
associated with bone marrow transplantation (BMT). Infection may lead to CMV disease …

Clinical evaluation of multiplex real‐time PCR panels for rapid detection of respiratory viral infections

SK Sanghavi, A Bullotta, S Husain… - Journal of medical …, 2012 - Wiley Online Library
Respiratory viral infections are one of the leading causes of morbidity and mortality,
particularly in children, the elderly and immunocompromised persons. Rapid identification of …

Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing …

LR Minces, MH Nguyen, D Mitsani… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Ganciclovir-resistant cytomegalovirus (CMV) infections are reported infrequently among
lung transplant recipients receiving extended valganciclovir prophylaxis. We performed a …

CMV pneumonia in HIV‐infected ventilated infants

P Goussard, S Kling, RP Gie, ED Nel… - Pediatric …, 2010 - Wiley Online Library
Background The contributing role of cytomegalovirus (CMV) in infants treated for
Pneumocystis jiroveci pneumonia (PJP) is unknown. High dose steroids used in the …

[PDF][PDF] Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone …

S Marchetti, R Santangelo, S Manzara… - … Quarterly Journal of …, 2011 - newmicrobiologica.org
Cytomegalovirus (CMV) infection is a frequent complication in transplant recipients. This
retrospective study compared real-time PCR (rt-PCR) and a pp65 antigen assay as tools for …

Monitoring and managing viral infections in pediatric renal transplant recipients

P Comoli, F Ginevri - Pediatric nephrology, 2012 - Springer
Viral infections remain a significant cause of morbidity and mortality following renal
transplantation. The pediatric cohort is at high risk of developing virus-related complications …